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Highlights 
 The N-alkyl amino acid moiety is widespread in Nature. 
 A number of commercial products related to health contain the N-alkylated amino acid moiety. 
 Biocatalysis can provide more efficient and sustainable methods of accessing the N-alkyl amino 
acid moiety than traditional methods.  
 Several new enzyme classes comprising N-methyl transferases and dehydrogenases can be 
used for the synthesis of N-alkyl amino acids. 
 
Abstract 
N-alkylated-α-amino acids are useful building blocks for the pharmaceutical and fine chemical 
industries. Enantioselective methods of N-alkylated-α-amino acid synthesis are therefore highly 
valuable and widely investigated. While there are a variety of chemical methods for their synthesis, 
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they often employ stoichiometric quantities of hazardous reagents such as pyrophoric metal hydrides or 
genotoxic alkylating agents, whereas biocatalytic routes can provide a greener and cleaner alternative 
to existing methods. This review highlights the occurrence of the N-alkyl-α-amino acid motif and its 
role in nature, important applications towards human health and biocatalytic methods of preparation. 
Several enzyme classes that can be used to access chiral N-alkylated-α-amino acids and their substrate 
selectivities are detailed. 
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1. The occurrence of N-alkyl-α-amino acids 
N-α-Alkylation represents one mechanism by which nature can modulate the activity of chiral α-amino 
acids. The most abundant are N-methyl-α-amino acids, encountered sometimes as the monomer, but 
more frequently, embedded within complex peptide or non-peptide natural products. Perhaps the most 
well studied natural N-methyl-α-amino acids are sarcosine (1) (N-methyl-α-L-glycine), N,N-
dimethylglycine (2) and betaine (3) (also known as glycine betaine) (Fig. 1). All three metabolites are 
ubiquitous in nature, produced by plants, animals and microorganisms. Each of these metabolites has 
valuable biological properties that have been the subject of much interest for potential commercial 
exploitation. Sarcosine (1), currently used as a dietary supplement and as a non-specific glycine 
transport inhibitor, also holds promise as an adjuvant therapy with sodium benzoate for the treatment 
of schizophrenia (Lin et al., 2017) and depression, as recently discussed in a review (Mathew, 2013). 
N,N-Dimethylglycine (2), which is also used as a dietary supplement, reportedly improves immune 
responses, acts as an athletic performance enhancer, displays anticonvulsant activity and may have use 
as an antidepressant in patients with autism (Lee et al., 2017). According to a recent review by Wilcken, 
glycine betaine (3) is used pharmaceutically in anhydrous form as Cystadane®, an adjunctive treatment 
for homocystinuria and can offer numerous other benefits to human health such as attenuation of liver 
injury (Wilcken, 2017).  
A broad range of betaines, of which glycine betaine (3) represents just one example, exist in nature and 
their main function is to act as osmolytes. They are produced in particularly high abundance (up to 4M 
concentrations) by organisms such as cyanobacteria, lichen, marine algae and salt tolerant plants 
(Chambers and Lever, 1996). Some examples of naturally occurring betaines include the marine indole 
alkaloids 5,6-dibromo-L-hypaphorine (4) and plakohypaphorine D (5), which also display antioxidant 
and antihistaminic activity respectively (Netz and Opatz, 2015).  
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Ribosomal peptides are of huge importance to the pharmaceutical industry, representing over sixty 
marketed drugs (Wegmuller and Schmid, 2014; Zompra et al., 2009). These range from short, 
chemically synthesised peptides of up to twenty residues, to peptides of up to 100 residues that are 
typically produced using recombinant DNA technology in mammalian, yeast or bacterial host systems. 
Ribosomal peptides and proteins frequently undergo post-translational modification via a broad variety 
of transformations (Nesterchuk et al., 2011) and the so-called ribosomally-synthesized and post-
translationally-modified peptides (RiPPs) have recently been comprehensively reviewed (Arnison et 
al., 2013). Post-translational modification at the α-nitrogen atom of N-terminal amino acid residues of 
linear ribosomal peptides (N-α-modification) is a common example of post-translational modification, 
typically occurring through N-acylation and less commonly through N-methylation (Ann et al., 1987). 
The N-methylation of side-chain residues of histone proteins has been extensively studied over the past 
20 years (Murn and Shi, 2017), whereas the role of methylation in other proteins and peptides, including 
N-α-methylation, is still largely unknown (Clarke, 2013; Erce et al., 2012). However, many of these 
peptides appear to function by interacting with proteins, often as part of extensive macromolecular 
complexes such as the epigenome and interactome.  
N-α-Methylation can have a profound effect on the biological activity of peptides. For example, 
cypemycin is a naturally occurring bacterial peptide that contains post-translational modifications, 
including N-α-dimethylation and displays potent antimicrobial activity and in vitro activity against 
mouse leukemia cells. Unlike cypemycin, its demethylated counterpart, prepared biosynthetically by 
deletion of the gene responsible for methylation, was inactive when tested towards growth inhibition of 
the gram-positive bacterium Micrococcus luteus (Claesen and Bibb, 2010). In contrast, with the 
intention of improving the stability of the antimicrobial peptide Nisin, which is used widely in the food 
industry, tandem N-α-monomethylation and lysine side-chain dimethylation, using the N-
methyltransferases (NMT) from the cypemycin biosynthetic pathway (CypM), resulted in a 
trimethylated derivative that displayed a 4 and 8-fold increase in minimum inhibitory concentration 
(MIC) towards Lactococcus Lactis HP (ATCC11602) and Bacillus subtillis 168 (ATCC6633) 
respectively (Zhang and van der Donk, 2012).  
Cyclic peptides are important in medicinal chemistry because they offer a number of advantages over 
acyclic peptides such as improved stability towards proteases, better membrane penetration and reduced 
toxicity due to enhanced receptor selectivity resulting from reduced conformational flexibility (Ripka 
et al., 1998). Cyclosporin A (6), which contains seven backbone N-methyl groups, represents an 
excellent example of a conformationally constrained cyclic non-ribosomal peptide (NRP). Approved 
by the FDA in 1983, it was still one of the top 100 selling brand name drugs in 2016 (Smith et al., 2016), 
marketed by Allergan under the trade name Restasis.  
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N-Methyl-α-amino acids are also found embedded into small non-peptoidal secondary metabolites. For 
example, 4-dimethylallyl-L-abrine (7) is a key intermediate in the biosynthesis of ergot alkaloids (Fig. 
1) (Rigbers and Li, 2008). 
 
 
 
Fig. 1. N-Methylated glycine primary metabolites of the folate cycle. 
Alkyl groups other than methyl can also be naturally incorporated into N-alkyl-α-amino acids. For 
example, opines are produced by a wide variety of organisms including bacteria, plants, and animals 
including humans (Kung and Wagner, 1970; Schrittwieser et al., 2015).  
The primary role of opines in many organisms is in anaerobic respiration (Grieshaber et al., 1994). In 
fact, the opine pathway is thought to be the oldest of four anaerobic respiration pathways, resulting from 
the high amino acid abundance and low oxygen levels present in primordial times and is still of key 
importance to organisms, such as marine invertebrates, that inhabit hypoxic environments (Harcet et 
al., 2013; Livingstone et al., 1983). There has also been extensive investigation into the role of opines 
in plant cancers, such as crown gall and hairy root disease, where pathogenic bacteria genetically modify 
plant cells by transferring bacterial plasmids to the plant chromosome, thereby facilitating the 
production of opines for use as nutrients and reducing microbial competition (Dessaux et al., 1993). 
The ability of these bacteria to transfer DNA to other organisms has met with significant interest, 
whereas, to the best of our knowledge there is little information on the bioactivity of opines or opine 
derivatives themselves. 
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A number of different opine families exist, most having a structure resulting from the reductive 
amination of an α-amino acid with an α-ketoacid, as typified by octopine (8). However, there are many 
other classes, such as opines that utilise alternative keto acids, or that utilise sugars rather than keto 
acids (Fig. 2) (Dessaux et al., 1993). One particularly interesting aspect of opines is that the majority 
contain one amino acid of common L-(S)-stereochemistry and the other with D-(R)-stereochemistry, 
where the unusual D-(R)-stereocentre is formed during the enzyme catalysed condensation reaction. 
However, L,L-(S,S)-opines, such as L,L-(S,S)-succinamoprine, have also been identified (Chilton et al., 
1985). A more complex example is that of a new class of bacterial opine metallophores, such as 
staphylopine (9) produced by Staphylococcus aureus, that play a key role in pathogenesis by 
sequestering metals from their host (Song et al., 2018). These are biosynthesised from three amino acids 
by the action of R-selective 3-amino-3-carboxypropyltransferase (nicotianamine synthase) catalysed N-
alkylation followed by S-selective coupling of the resultant product to a further α-ketoacid by an opine 
dehydrogenase (McFarlane et al., 2018; McFarlane and Lamb, 2017). 
 
Fig. 2. Some examples of naturally occurring opines. 
Other N-α-alkyl groups of amino acids seem to be quite rare or are perhaps embedded into biosynthetic 
pathways that have yet to be elucidated. One such example that has been identified is (S)-N-
carboxyethyl arginine (10) which is an intermediate in the biosynthesis of clavulanic acid (Elson et al., 
1993), a commercial β-lactamase inhibitor that is frequently administered with penicillin antibiotics to 
minimise drug resistance.  This unusual functionality is introduced by the rare thiamine diphosphate 
(ThDP) dependent carboxyethylation of arginine by the N2-(2-carboxyethyl)arginine synthase (CEAS) 
enzyme (Caines et al., 2009).  
2. Preparation of N-alkyl-α-amino acids 
The chemical synthesis of N-alkyl-α-amino acids is usually performed by N-alkylation processes, which 
employ genotoxic alkylating agents, or reductive amination, utilizing stoichiometric quantities of 
hazardous hydrides which requires complex work-up procedures and the generation of significant waste 
(Aurelio et al., 2004; Aurelio and Hughes, 2009; Baxter, 2004; Chruma et al., 1997).  Various 
asymmetric reductive amination methods have also been reported (Arceo and Melchiorre, 2012; Chen 
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et al., 2009a; Kuang and Distefano, 1998; So et al., 2012), but they each suffer from limitations such as 
narrow substrate range, use of heavy metals, or the requirement to pre-form the imine to avoid ketone 
reduction (Aurelio et al., 2004). Biocatalysis offers a less hazardous and wasteful alternative to 
traditional chemical synthetic methods. Therefore, given the wide variety of natural products that 
contain N-alkyl-α-amino acids, it is not surprising that many enzyme classes, such as N-
methyltransferases and several dehydrogenases, have the potential to be used for N-alkyl-α-amino acid 
synthesis. The use of these enzymes for N-alkyl-α-amino acid synthesis is an emerging field and is the 
focus of this section. 
2.1. N-methyltransferases 
N-Methyltransferases (NMT, EC 2.1.1), are ubiquitous in nature and are responsible for the methylation 
of a broad range of natural products including the N-α-methylation of many of the amino acids, peptides 
and proteins mentioned above.  
These enzymes are highly versatile and depending on their function, can be either highly substrate 
selective or promiscuous, producing mono-, di- or trimethylated products. For example, in mammalian 
systems, sarcosine (1) is produced by the selective mono-methylation of glycine (11) by S-
adenosylmethionine (SAM) dependent glycine sarcosine methyltransferase (GSMT), whereas N,N-
dimethyl glycine (2) and glycine betaine (3) are only accessible from choline (Ducker and Rabinowitz, 
2017). A similar pathway is followed in most other organisms, but there are some rare examples of 
bacteria, that inhabit hypersaline environments, which can produce glycine betaine (3) via a sequential 
3-step methylation of glycine using GSMT, sarcosine dimethylglycine methyltransferase (SDMT) and 
dimethylglycine methyltransferase (DMT) respectively (Scheme 1) (Zou et al., 2016). 
 
Scheme 1. Biosynthesis of glycine betaine from glycine by sequencial methylation that is known to occur 
in some halophilic bacteria. 
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A few examples of broad substrate spectrum NMTs, that are capable of direct conversion of amino 
acids to betaines, have also recently been reported. For example, histidine betaine, an intermediate in 
the biosynthesis of ergothioneine, is produced directly from histidine in Mycobacterium smegmatis 
solely by the histidine betaine synthase, EgtD (Vit et al., 2015). Unfortunately, EgtD only accepts 
histidine as substrate, but genome searching identified numerous homologues in bacterial and fungal 
genomes. Based on this search, the EgtD homologue from Aspergillus nidulans, recombinantly 
expressed in E. coli, showed a preference for tyrosine, although histidine, dihydroxyphenylalanine and 
phenylalanine were tolerated with lower efficiency. In contrast, the halophilic methanoarchaeon 
Methanohalophilus portucalensis strain FDF1T contains NMTs capable of both stepwise and direct 
glycine betaine formation (Chen et al., 2009b). Examples of individual NMTs involved in the stepwise 
conversion and direct conversion of amino acids to betaines have also been heterologously expressed 
in E. coli in an active form (Lai and Lai, 2011).  
NMTs involved in the terminal N-α-methylation of peptides and proteins are common and are usually 
promiscuous towards the peptide sequences they accept, often N-α-methylating a range of peptides to 
different extents and sometimes their sidechains as well. For example, CypM, which is the NMT 
responsible for the introduction of the N-α-dimethylation functionality of cypemycin has been 
demonstrated to methylate a range of short heptapeptides that resemble the N-terminus of the natural 
substrate, as well as the unrelated antimicrobial peptides, nisin and halodracin (Zhang and van der Donk, 
2012). However, this is not always the case as demonstrated by the very selective PZN 
methyltransferase. This enzyme is highly selective towards the N-α-dimethylation of the highly post-
translationally modified peptide desmethylplantazolicin to afford plantazolicin (PZN), an antibiocobial 
peptide with bacteriocidal activity toward strains of Bacillus anthracis, the causative agent of anthrax 
(Lee et al., 2013).  
In contrast to ribosomal peptides, NRPs are backbone N-methylated by methylation domains at the 
terminal N-α-position of amino acids or peptides, attached to the same non-ribosomal peptide synthase 
(NRPS) at peptidyl carrier protein (PCP) regions through thioester linkages (Mori et al., 2018). 
However, with the aim of improving titres, a second mechanism was recently found when investigating 
the biosynthetic pathway to the fungal metabolite cycloaspeptide E5 (12) that displays interesting 
insecticidal activity (de Mattos-Shipley et al., 2018). Unexpectedly, the NRPS required directly 
incorporates N-methyl phenylalanine that is pre-formed by an NMT. This allowed the titre of (12) to be 
greatly increased by direct feeding of N-α-phenylalanine to the fermentation. Unfortunately, the NRPS 
accepted a very narrow range of alternative substrates, although N-methyl-para-fluorophenyl alanine 
was accepted, allowing access to the difluorinated analogue (13) (Fig. 3). Searching the NCBI database 
for homologues of the cycloaspeptide E NMT gene, PscyA, the same authors rapidly identified a 
homologue involved in the biosynthesis of the fungal metabolite ditryptophenaline (14). Taking the 
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same feeding approach, a difluorinated analogue of ditryptophenaline (15) was also prepared, implying 
that numerous fungal NMTs capable of N-α-methylating amino acids probably exist.  
 
Fig. 3. Some NRPs and their fluorinated analogues that can be prepared through introduction of intact N-
α-methylamino acids to the fermentation process. 
SAM and its analogues are expensive to use in stoichiometric quantities, which has hampered the use 
of NMTs in in-vitro preparative biotransformations. This has led to methods of in-situ generation from 
cheap materials, such as the tandem use of SalL, an enzyme which catalyses the alkylation of 5’-deoxy-
5-chloroadenosine with methionine and its S-alkyl analogues (Sadler et al., 2017). Whereas the use of 
these approaches is still at an early stage, they hold much promise for the future as methods of green 
and sustainable O-, N- and C-alkylation. 
2.2. Dehydrogenases 
While there are many enzymes which can carry out reductive amination using ammonia, few examples 
are known to employ alkyl amines (Hummel and Groger, 2012; Schrittwieser et al., 2015; Sharma et 
al., 2017). Classes of enzymes that are now known to perform this transformation include opine 
dehydrogenases (ODHs), N-methyl amino acid dehydrogenases (NMAADHs), ketimine reductases 
(KIREDs), pyrroline-5-carboxylate reductases (P5CRs) and imine reductases (IREDs), each of which 
is discussed below.  
2.2.1. Opine dehydrogenases  
Opine dehydrogenases (ODHs) are oxidoreductases whose natural role is to catalyse the reductive 
amination of α-keto acids with amino acids to provide N-carboxylalkyl amino acids (Scheme 2), a class 
of compounds known informally as opines. Octopine dehydrogenase (OcDH, EC 1.5.1.11) was the first 
ODH to be identified in 1959, when Van Thoai et al. synthetized D-octopine (8) in vitro from arginine 
and pyruvic acid in the presence of various enzyme preparations from marine invertebrates (Van Thoai 
and Robin, 1959). A decade later the same group purified the NADH dependent OcDH from mussels 
of Pecten maximus (Van Thoai et al., 1969). 
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Scheme 2. ODH type catalysed reactions. 
Other examples have since been identified in the soil bacteria, Agrobacterium tumefaciens (Heidekamp 
et al., 1983) and Arthrobacter sp. strain 1C (Asano et al., 1989; Dairi and Asano, 1995). Asano et al. 
assessed the substrate specificity of ODH using various amines against pyruvate as the α-keto acid. L-
Methionine proved to be the favoured substrate followed closely by L-isoleucine, L-valine, L-
phenylalanine, L-leucine, L-alanine, L-threonine, L-cysteine, L-serine, glycine and L-asparagine. A few 
other amino acids such as β-alanine or L-histidine were not tolerated and no product was observed 
(Asano et al., 1989). The same group also examined the preparative potential of the ODH from 
Anthrobacter sp. strain 1C and found it to give a different substrate selectivity pattern (Kato et al., 
1996). The enzyme was cloned and recombinantly expressed in E. coli and shown to accept a wide 
range of amino acids as amine donors on reaction with pyruvic acid (Table 1).  Interestingly, (S)-
phenylalaninol (26), a non-zwitterionic amine, was tolerated as the amine donor and to the best of our 
knowledge, is the only example of a non-amino acid amine donor accepted by a wild-type enzyme of 
this class. Glyoxylate and 2-ketobutyrate were also accepted when reacted with L-isoleucine and L-
valine, suggesting that the substrate scope could be extended.  The reductive amination of this ODH 
proceeds with high D-(R)-stereoselectivity (>99%) that is common to many, but not all enzymes of this 
class. This is in contrast with the strict L-(S)-selectivity of other enzymes capable of N-alkylating α-
amino acids. 
Table 1. Selected substrate specificity of D-(R)-selective opine dehydrogenase from Arthrobacter sp. strain 
1C in reaction with pyruvate (16). 
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Amine donor Relative activity Amine donor Relative activity 
 
17 
100 
 
18 
21 
 
19 
84  
20 
0.7 
 
21 
72 
 
22 
4 
 
23 
53 
 
24 
22 
 
25 
24  
26 
0.6 
 
27 
16 
 
28 
36 
 
ODHs are usually highly substrate specific, as demonstrated by the ODH from Pecten maximus which 
accepts pyruvic acid (16) and arginine as substrates (Smits et al., 2008). Other amino acid donors such 
as canavanine (25%), cysteine (1.2%), L-alanine (<1%), ornithine (<1%) and norvaline (<1%), display 
reduced or negligible activity. Another example is the OcDH from Mytilus galloprovincialis, which 
accepts alanine with approximately 10-fold less activity than arginine (88% versus 9%) (Vazquez-
Dorado et al., 2011). 
In invertebrates there are many types of ODH that have been identified such as alanopine 
dehydrogenases (EC 1.5.1.17; AlDH) (Storey, 1983); β-alanopine dehydrogenases (EC 1.5.1.26; β-
AlDH) (Kan-no et al., 1999; Sato et al., 1987); strombine dehydrogenases (EC 1.5.1.22; StDH) (Dando, 
1981) and tauropine dehydrogenases (EC 1.5.1.23; TaDH)(Gaede, 1986). It should be noted that these 
classifications are based on their preferred substrate specificity, and there is cross reactivity between 
ODH classes as many of these enzymes accept substrates of other classes, but with lower activities.  
This can be seen from the work of Sato et al. who tested a variety of ODHs from different marine 
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organisms towards various amino acid donors and demonstrated that most display a range of activities 
(Sato et al., 1993). AlDHs, for example, primarily operate on alanine. However Storey et al. tested the 
substrate specificity of AlDH from Aphrodite aculeata and found thatseveral other amino acids were 
accepted, including glycine, serine and threonine, and a relatively broad range of keto acids (Table 2) 
with varying efficiencies (Storey, 1983).  
Table 2. Selected keto acids specificity of AlDH from Aphrodite aculeate in reaction with L-alanine. 
 
Keto acid VMAX Amine donor VMAX 
 
16 
100 
 
29 
21 
 
30 
26 
 
31 
107 
 
The value of these enzymes came to the attention of Codexis Inc. as a potential imine reduction platform 
if the substrate scope could be broadened to include other ketones and amines. They performed  
extensive engineering on Anthrobacter sp. opine dehydrogenase to expand the accepted substrate scope 
and identified mutants capable to tolerating substrates such as butylamine, cyclopentanone and an 
expended range of keto acids (Scheme 3) (Chen et al., 2013). However, these findings have not been 
disclosed outside of a patent and many details, such as the level of activity, enantioselectivity and exact 
sequences of the enzyme mutants, remain unclear. 
 
AC
CE
PT
ED
MA
NU
SC
RI
PT
12 
 
Scheme 3. Examples of reactions carried out by evolved opine dehydrogenases. 
2.2.2. N-Methyl amino acid dehydrogenases  
N-Methyl amino acid dehydrogenases were first discovered in 1970 by Kung and Wagner (Kung and 
Wagner, 1970). They reported the formation of N-methylalanine when cell free extracts of 
Pseudomonas MS were treated with methylamine. In 1975, the same group managed to purify and 
characterise the enzyme, which they named N-methyl amino acid dehydrogenase for its ability to 
catalyse the reductive amination of pyruvate and methylamine (Scheme 4) (Lin and Wagner, 1975). N-
Methyl amino acid dehydrogenases (NMAADHs, EC 1.5.1.1 and EC 1.5.1.21) are also known as Δ1-
piperideine-2-carboxylate/Δ1-pyrroline-2-carboxylate reductases (dPkAs), Pip2CRs or Pyr2CRs. 
 
Scheme 4. NMAADHs from Pseudomonas MS producing N-methylalanine. 
Substrate and cofactor specificity were also explored to determine whether other keto acids or amine 
sources could be accepted by the enzyme. When NADPH was substituted with NADH, conversions 
dropped from 100% to 4% for the reaction of pyruvate with methylamine. Other keto acids such as 
oxaloacetate and α-ketobutyrate were tolerated with diminished efficiency (64% and 14% respectively, 
relative to pyruvate) in the reaction with methylamine, whilst glyoxalate, hydroxypyruvate and α-
ketoglutarate were not tolerated. Ethylamine and dimethylamine were not tolerated as substrates in the 
presence of pyruvate and crucially, little activity was observed towards ammonia.  
Mihara et al. later found that the NMAADH from Pseudomonas putida ATCC12633 is also capable of 
performing the reductive amination between a number of additional α-keto acids and methylamine 
(Mihara et al., 2005). After it was cloned and expressed in E. coli, the enzyme displayed moderate 
activity towards fluorinated, aromatic and aliphatic pyruvate derivatives, but hydroxy and branched 
chain derivatives such as α-oxoisovalerate  (42) were inert, with pyruvate being the best keto acid tested 
(Table 3). 
Table 3. Reductive amination of some pyruvates with methylamine (36) with Pseudomonas putida 
NMAADH. 
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Keto acid Relative activity Keto acid Relative activity 
 
16 
100 
 
38 
27 
 
39 
52 
 
40 
6 
0 
41 
30 
 
42 
0 
 
Table 4 shows the relative activity of Pseudomonas putida NMAADH towards the reductive amination 
of phenylpyruvate (41) with a range of amines, with methylamine (36) being the most effective by a 
large margin (Mihara et al., 2005). An increase of one carbon to (43) gives a large decrease in activity. 
As the chain length increases the activity continues to decrease, however the enzyme does tolerate large 
amines (such as spermidine (49)) to a small degree. Interestingly, this enzyme is inactive with ammonia 
and therefore does not form primary amines.  
Table 4. The relative activity of Pseudomonas putida NMAADH.  
 
Amine 
Relative 
activity 
Amine 
Relative 
activity 
 
36 
100  
43 
4.4 
 
44 
0.74  
45 
0.16 
 
46 
0.12 
 
47 
<0.06 
 
48 
0  
49 
<0.06 
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In 2004, the Esaki group demonstrated the synthetic utility of this enzyme by successfully producing 
N-methyl-L-phenylalanine on a 1.6 g scale with good yield and high enantiomeric excess by using 
NMAADH from Pseudomonas putida and glucose dehydrogenase from Bacillus subtilis (Muramatsu 
et al., 2004). Further studies from the same group have shown that NMAADHs can also accept a wide 
range of cyclic imino acids such as Δ1-piperideine-2-carboxylate and Δ1-pyrroline-2-carboxylate 
(Yasuda et al., 2006). Cyclic imino acids were produced spontaneously from their corresponding α-
keto-ω-amino acids which, in turn, produced from their corresponding α,ω-diamino acids using amino 
acid oxidases. One of their best examples is highlighted in Scheme 5 where (S)-(53) was obtained in 
high yield tandem use of lysine oxidase and NMAADH.  
 
Scheme 5. Lysine degradation pathway steps incorporating NMAADHs.  
Further studies have shown that NMAADHs from Pseudomonas putida can reduce a number of 2,3,4,5-
tetrahydropyridine-6-carboxylate compounds containing oxygen or sulphur within the ring. (Esaki et 
al., 2008) Δ1-Piperideine-2-carboxylate and Δ1-pyrroline-2-carboxylate reductases have been also 
demonstrated to be involved in the catabolism of D-lysine and D-proline (Muramatsu et al., 2005). 
Recently, researchers from GSK have demonstrated that both keto acid and amine substrate scope can 
be further expanded with excellent enantioselectivities by using NMAADHs from Pseudomonas putida, 
P. syringae and P. fluorescens (Table 5) (Hyslop et al., 2018). 
Table 5. Example of NMAADH catalysed reductive amination. 
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Amine 
Conversions of NMAADHs 
Pseudomonas  
putida 
Pseudomonas  
syringae 
Pseudomonas  
fluorescens 
 
36 
97 98 98 
 
43 
16 6 5 
 
54 
12 6 5 
 
55 
92 52 58 
 
56 
59 27 29 
 
2.2.3. Ketimine reductases  
Ketimine reductases (KIREDs, EC 1.5.1.25) are another class of enzyme that can carry out the reductive 
amination of imino acids.  They were first discovered in mammalian tissues such as rat kidney, brain, 
liver, testes, heart, skeletal muscle and spleen (Meister, 1962; Meister et al., 1957)  and rabbit liver 
(Meister and Buckley, 1957) and have been shown to catalyse the conversion of Δ1-piperideine-2-
carboxylate and Δ1-pyrroline-2-carboxylate  to their corresponding saturated cyclic amino acids (Table 
6, Entries 1-2). Even though KIREDs perform the same natural reaction as NMAADHs, they are 
structurally distinct (Hyslop et al., 2018). Plant extracts from Pisum sativum and Phaseolus radiatus 
also catalyse the conversion of Pyr2C (52) to pipecolic acid (53), but detailed studies of the plant tissues 
were not performed. The activity of the plant extracts was found to be of the same order of magnitude 
as that observed with rat liver (Meister et al., 1957).  
These enzymes, later found to also reside in pig kidney (Nardini et al., 1988a) and in brain μ-Crystallin 
(CRYM) (Hallen et al., 2011), have also been shown to reduce a variety of naturally occurring sulphur 
containing cyclic imino acids (Table 6). These compounds are found in varying concentrations within 
the human brain, although the relative activities of KIREDs towards these sulfur containing compounds 
was not specified (Hallen et al., 2015a). 
Interestingly, both NADH and NADPH appear to be accepted equally in the case of pig kidney KIRED 
and cerebral l-crystallin/KIRED, but NADPH is the preferred cofactor for cerebellum KIRED. All 
KIREDs display a strict enantio-preference for the formation of L-alkyl-α-amino acids.  
Table 6. KIRED substrate scope. 
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Substrate Enzyme Source Product Reference 
 
52 
Mammalian 
tissues 
 
53 
(Meister and Buckley, 1957) 
(Meister et al., 1957)  
(Meister, 1962) 
Pig kidney (Nardini et al., 1988a) 
Bovine Crebellum (Nardini et al., 1988b) 
 
54 
Mammalian 
tissues 
 
55 
(Meister and Buckley, 1957) 
(Meister et al., 1957) 
(Meister, 1962) 
  
56 
CRYM/ Lamb 
forebrain 
 
57 
(Hallen et al., 2011) 
 
Pig kidney (Nardini et al., 1988a) 
Bovine Crebellum (Nardini et al., 1988b) 
 
58 
Pig kidney 
 
59 
(Nardini et al., 1988a) 
Bovine 
Cerebellum 
(Nardini et al., 1988b) 
 
60 
Pig kidney 
 
61 
(Nardini et al., 1988a) 
Bovine 
Cerebellum 
(Nardini et al., 1988b) 
 
62 
Cerebellum 
 
63 
(Hallen et al., 2014) 
 
Hallen et al. further extended the substrate scope of the KIREDs by demonstrating that human ketimine 
reductase/CRYM, recombinantly expressed in Escherichia coli and purified, could catalyse the 
synthesis of four N-functionalised L-alkyl-α-amino acids (Table 7) (Hallen et al., 2015b). The relative 
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rates quoted in Table 7 are shown in comparison to piperideine-2-carboxylate and as can be seen, the 
rates for the acyclic keto acids are far lower, but still significant.  
Table 7. Conversions of N-Functionalised amino acids synthesised using KIRED.  
 
Ketone  Amine  Relative rate 
 
16 
 
36 
25 
 
16 
 
43 
24 
 
64 
 
36 
16 
 
41 
 
36 
12 
 
The biocatalytic utility of KIREDs has recently been further demonstrated by Hyslop et al. (2018). 
Three recombinant KIREDs, which were cloned and expressed well in E. coli, were used to prepare a 
variety of phenylalanine derivatives on reaction with amines such as methylamine, propargylamine and 
benzylamine with pyruvate (Table 8). Conversions ranged from 32-81% in the case of methyl amine 
and were low to moderate when propargyl amine was used as amine donor (19-26%). Cyclopropyl 
amine was also accepted in good conversions (up to 79%) at 10 mM keto acid concentration. 
Table 8. Enzymatic reductive amination conversions for phenylpyruvic acid (41) catalysed by KIREDs. 
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Amine 
Relative activity 
Rattus 
norvegicus 
Homo  
sapiens 
Bos  
taurus 
 
36 
51 81 32 
 
43 
5 9 2 
 
54 
16 30 10 
 
55 
19 24 26 
 
56 
43 79 29 
2.2.4. Imine reductases  
Imine reductases carry out the reduction of cyclic imines but have also been exploited in reductive 
amination reactions (Aleku et al., 2017; Cosgrove et al., 2018; Roiban et al.; Roth et al.; Velikogne et 
al., 2018). Despite the number of diverse IREDs reported, to the best of our knowledge, there is only 
one example demonstrating activity towards an α-keto acid. Aleku et al. screened the AspRedAm 
towards multiple substrates including pyruvate (16), in the presence of methylamine and 
propargylamine (Scheme 6) (Aleku et al., 2017).  However, in the presence of a large excess of the 
amine donor (>4 equivalents) only modest activities were observed of 3% for methylamine (36) and 
4% for propargylamine (55).  
 
Scheme 6. IRED catalysed reductive amination of pyruvate (16) with ethylamine (43). 
As research into the IRED field continues to expand rapidly, with many examples of new enzymes and 
evolution projects, it is likely that more effective examples will be identified in the coming years. 
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2.3. Other enzyme classes 
There are a few other examples of some specific enzymes able of forming N-functionalized amino acids. 
Pyrroline-5-carboxylate reductases (P5CRs, EC 1.5.1.2) are a class of enzymes involved in the 
biosynthesis of proline, which is formed following reduction of pyrroline-5-carboxylate (Singh et al., 
2013). They are perhaps the least characterised of the oxido-reductases described in this chapter in spite 
of their substrate similarity to that of NMAADHs and KIREDs (Yura, 1959). While several P5CR 
examples have been identified, none have been used in preparative synthesis. The P5CR from 
Neurospora crassa has been recently screened towards a panel of substrates and accepts methylamine, 
ethylamine, allylamine and propargylamine with conversions varying from 2% up to 82% (Hyslop et 
al., 2018). While only one enzyme has been demonstrated to have this activity, there is potential to 
further explore this enzyme class for amino acid synthesis activity. 
Ammonia lyases (AL, EC 4.3.1) are enzymes commonly found in plants and fungi, which carry out 
either the deamination of amino acids to α,β-unsaturated carboxylic acids and ammonia or the reverse 
amination process (Lovelock and Turner, 2014). These enzymes accept ammonia as their amine source, 
but there are very few examples of any other amines being accepted. Viergutz et al. demonstrated that 
a wild type PAL (from P. crispum) was able to deaminate N-methyl phenylalanine (62), but did not 
carry out the reverse reaction at a detectable rate (Viergutz et al., 2003). Additionally, this PAL did not 
accept 4-nitro-N-methyl phenylalanine or 4-nitro-N,N-dimethyl phenylalanine in either direction.  
Preparation of N-substituted aspartic acids via enantiospecific conjugate addition of N-nucleophiles to 
fumaric acids has been successfully demonstrated by Gani et al. using methylaspartase (Saeed Gulzar 
et al., 1997). Aspartate ammonia lyase is another enzyme type which proved to be an excellent catalyst 
for the synthesis of N-substituted aspartic acids. In this context Weiner et al. demonstrated the 
enantioselective AspB-catalyzed addition of methylamine to fumarate (Weiner et al., 2008). 
3. Conclusions 
N-functionalised amino acids are versatile building blocks for the pharmaceutical and fine chemical 
industries and are particularly important starting materials for peptide drugs. There are now a variety of 
preparative biocatalytic options to access these materials in enantiopure form, therefore offering a 
cleaner and greener alternative to chemical synthetic methods which often employ heavy metal 
catalysts, toxic reagents, environmentally unfriendly solvents and the extensive use of protecting 
groups. We anticipate they will supplant current chemical methods as improved, engineered enzyme 
variants for these transformations become available. 
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